3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Breast Neoplasms
3
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Cervical Cancer
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Motor Activity
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Lymphoid
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gynecologic Cancer
1
Genetic Testing
1
Interventions
Magnetic Resonance Spectroscopy
13
Temozolomide
11
Specimen Handling
8
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Radiation
5
Phantoms, Imaging
5
erdafitinib
4
ulixertinib
3
trametinib
3
larotrectinib
3
dabrafenib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
olaparib
2
ivosidenib
2
ensartinib
2
binimetinib
2
D2C7-(scdsFv)-PE38KDEL
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tazemetostat
1
selinexor
1
sapanisertib
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Surveys and Questionnaires
×
30 days
×
Clear all
No trials found.